Janney Montgomery Scott Starts Jazz Pharmaceuticals (JAZZ) at Neutral

August 25, 2016 8:11 AM EDT
Get Alerts JAZZ Hot Sheet
Price: $128.61 +11.28%

Rating Summary:
    28 Buy, 4 Hold, 0 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 13 | Down: 22 | New: 54
Trade JAZZ Now!
Join SI Premium – FREE

Find out which companies are about to raise their dividend well before the news hits the Street with StreetInsider.com's Dividend Insider Elite. Sign-up for a FREE trial here.

Janney Montgomery Scott initiated coverage on Jazz Pharmaceuticals (NASDAQ: JAZZ) with a Neutral rating.

For an analyst ratings summary and ratings history on Jazz Pharmaceuticals click here. For more ratings news on Jazz Pharmaceuticals click here.

Shares of Jazz Pharmaceuticals closed at $129.96 yesterday.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

New Coverage

Related Entities

Janney Montgomery Scott

Add Your Comment